Marshall Wace, LLP Mednax, Inc. Transaction History
Marshall Wace, LLP
- $77.3 Billion
- Q3 2024
A detailed history of Marshall Wace, LLP transactions in Mednax, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 34,300 shares of MD stock, worth $432,523. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,300
Previous 134,191
74.44%
Holding current value
$432,523
Previous $1.01 Million
60.81%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding MD
# of Institutions
222Shares Held
85.3MCall Options Held
28.6KPut Options Held
4.1K-
Black Rock Inc. New York, NY13.7MShares$173 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.7MShares$135 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY8.28MShares$104 Million2.67% of portfolio
-
Alliancebernstein L.P. New York, NY8.11MShares$102 Million0.03% of portfolio
-
State Street Corp Boston, MA3.54MShares$44.6 Million0.0% of portfolio
About MEDNAX, INC.
- Ticker MD
- Exchange NYSE
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 84,353,504
- Market Cap $1.06B
- Description
- Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals thr...